Working together to keep Australians healthy through research innovation.
Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.
Enabling Health Innovation and Translation
For further information about the NCRIS Health Group, please contact:
Health Group infrastructure
The Health Group offers seamless access to world class research infrastructure and expertise.
The NCRIS Health Group is a cross-capability collaboration established via a Collaboration Agreement. The Group is coordinated via a leadership group comprising the Board Chairs and Chief Executives of the five member capabilities.
National Collaborative Research Infrastructure Strategy (NCRIS)
NCRIS Health Group Highlights
Australian health research infrastructure underpins world-first brain cancer collaboration
The NCRIS Health Group will support Australian brain cancer research through Brain Cancer Biobanking Australia’s project to develop an integrated network of research platforms to improve
Probing the protein factories of the cell to treat rare diseases
Frequently referred to as the building blocks of life, proteins are vital in all cells in all living organisms. That puts ribosomes—the structures responsible for protein
Accelerate your Translational Research with NCRIS
Pipeline Accelerator 2022-23 Round 2 Info session Phenomics Australia joins Therapeutic Innovation Australia (TIA) Pipeline Accelerator voucher scheme Through the National Collaborative Research Infrastructure Strategy (NCRIS)
National research infrastructure working together to improve the health of Australians
Innovation in Australia’s health and medical research translation has been boosted with National Collaborative Research Infrastructure Strategy (NCRIS)- enabled health and medical research partners signing a
Phenomics Australia and Therapeutic Innovation Australia enhancing collaborative opportunities through the Victorian Centre of Functional Genomics
Phenomics Australia and TIA co-investment in the Victorian Centre of Functional Genomics (VCFG) The Victorian Centre for Functional Genomics (VCFG) has been a Phenomics Australia NCRIS
Meet Dr John Parisot the new Phenomics Australia Strategic Partnerships Advisor
We would like to welcome Doctor John Parisot to Phenomics Australia’s team. John brings a wealth of experience in therapeutic R&D, project management, and functional genomics
ANU-Genentech collaboration exposes a new mechanism involved in sepsis
A gene involved in the development of sepsis has been discovered by a long-standing collaboration between teams at The Australian National University (ANU), including the Australian